Healthcare
3i makes 3.5x money on Ambea sale to Triton
3i has divested its stake in healthcare and care services provider Ambea in a тЌ850m secondary buyout to Triton.
Q&A: Early-stage evolution
Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.
EQT's Actavis still in the race for for ratiopharm
According to reports, EQT-backed Actavis is still left in the race for generic drugs group ratiopharm being sold by VEM Vermoegensverwaltung GmbH.
CapMan invests in Hermelinen
CapMan has invested the Swedish private health care centre Hermelinen.
CRB's OWL Genomics acquires 70% stake of MD Renal
Cross Road Biotech (CRB) portfolio company OWL Genomics has acquired a 70% stake in sector business MD Renal.
Aescap-backed Biocartis acquires Philips Technology Platform
Aescap-backed molecular diagnostics company Biocartis has acquired Philips’ technology platform for rapid fully-automated DNA/RNA molecular diagnostic testing.
Volati acquires Team Ortopedteknik
Swedish buyout house Volati has acquired orthopaedic technology company Team Ortopedteknik
Waterland backed Medhold sold to Sonic Healthcare
Waterland Private Equity has divested its stake in Belgian laboratory business Medhold Group to Australian-based Sonic Healthcare who has fully acquired the business.
Strong research bodes bright future for Dutch venture
The Netherlands’ excellence in the fields of ICT and Life Sciences is driving dealflow up and prompting optimism for the future. By Francinia Protti-Alvarez
Argos Soditic reaps more than 4.5x on Dinno Santé exit
Argos Soditic, FHH Conseil and the management have sold their 100% stake in Dinno Santé to the healthcare business of Air Liquide and in doing so have realised over 4.5x return.
BioMedPartners strengthens management team
Healthcare venture firm BioMedPartners has strengthened its management with Josef Bissig as new venture partner.
LSP in €21.7m series B round for Merus
Life Sciences Partners (LSP), Novartis Option Fund, Pfizer and Bay City Capital have co-led a €21.7m series B financing round for biopharmaceutical Merus.
CZECH/POLAND - ARX backs opthamology bolt-on
CEE GP ARX Equity Partners has backed its Czech portfolio company Lexum Group in its acquisition of Intermedica, a private Polish opthamology chain.
GERMANY - HTGF and Life Science Fonds Esslingen invest in Amedrix
High-Tech Gruenderfonds and Life Science Fonds Esslingen have jointly invested a total of EUR 700,000 in the medical implants developer Amedrix GmbH.
UK - Finance Wales invests £315,000 into Ocelus
Finance Wales has invested ТЃ315,000 in drug company Ocelus as part of a second funding round worth close to ТЃ500,000.
UK - Duke Street sells Affinity to Priory
Duke Street Capital has sold UK mental healthcare business Affinity Healthcare to The Priory Group for an undisclosed sum.
GERMANY - Earlybird leads EUR 3m round for EBS Technology
Earlybird has led a EUR 3m investment in medical device business EBS Technology GmbH, together with BC Brandenburg Capital.
FRANCE - Duke Street exits Proclif
Duke Street Capital has sold its remaining 57% interest in Proclif, a private hospital company, to Predica, an insurance division of Crédit Agricole, which has in turn sold the stake on to Australian business Ramsay Healthcare for a reported EUR 87m....
GERMANY - SHS invests in TNI medical
SHS Gesellschaft für Beteiligungsmanagement has, together with KfW bank and management, acquired a majority stake in medical technology firm, TNI medical AG.
SWITZERLAND - BioMedPartners reaches final close on CHF 106m
Healthcare venture firm BioMedPartners has reached the final close for BioMedInvest on CHF 106m.
SWEDEN - Industrifonden exits Envirotainer to AAC
Swedish investor Industrifonden has exited Envirotainer, a supplier of temperature controlled logistics to the pharmaceutical industry, in a secondary buyout to AAC Capital Partners.
FRANCE - BC Partners-backed Médica prepares IPO
It is understood that BC Partners is readying to list its Paris-based care homes group Médica, with bookbuilding set to commence on 25 January with BNP Paribas, Credit Suisse and Royal Bank of Scotland as bookrunners.
NETHERLANDS - Thuja et al. in series-A round for FABPulous
Thuja Capital, Health Innovation Fund, Limburg Ventures and NV Industriebank LIOF have co-led an indisclosed investment into biotechnology firm FABPulous, in a first round of institutional funding.